Related Experiment Video

Updated: Aug 4, 2025

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

Covid-19 Study, Diagnostic and Therapeutic Transition

Da Yong Lu¹, Ting Ren Lu²

¹School of Life Sciences, Shanghai University, Shanghai, 200444, China.

Recent Advances in Anti-Infective Drug Discovery

|March 31, 2023

Insights

Global COVID-19 management has advanced with formalized diagnostics and therapeutics. Continued research into viral biology and dynamic updates to biomedical knowledge are crucial for future pandemic preparedness.

Area of Science:

Virology
Epidemiology
Public Health

Background:

The COVID-19 pandemic, caused by SARS-CoV-2, emerged three years ago, revealing significant global disparities in healthcare responses and legislation.
Despite initial challenges, social and healthcare systems worldwide have adapted, formalizing diagnostic and therapeutic protocols.

Purpose of the Study:

To analyze the evolution of COVID-19 diagnosis and therapeutics globally over the past three years.
To highlight the need for continued research into SARS-CoV-2 biology and the development of novel countermeasures.
To establish a framework for diagnostic and therapeutic transitions considering diverse socioeconomic conditions and policies.

Main Methods:

Review of formalized diagnostic and therapeutic strategies, including vaccines and drug regimens.
Investigation into the viral origins, biology, and strain-specific drug targeting of SARS-CoV-2.
Analysis of the role of animal models and pathophysiological knowledge in understanding COVID-19.

Main Results:

Diagnostic advancements and therapeutic selections worldwide have improved patient outcomes and curability.
Understanding viral spread and mortality, alongside existing knowledge, has been vital in managing the pandemic.
The emergence of COVID-19 variants necessitated adaptive therapeutic strategies.

Conclusions:

Diverse diagnostic platforms offer varied therapeutic options, influencing patient response and clinical benefits.
Advanced diagnostic dimensions and therapeutic paradigms are essential for optimizing COVID-19 patient recovery.
Continuous updates in biomedical knowledge, vaccines, and therapeutic strategies are imperative for global health security.

Read full analysis

Abstract

Introduction:

The outbreak of coronavirus (severe acute respiratory syndrome coronavirus2, COVID-19, SARS-Co-2) in Wuhan, China occurred three years ago. However, the healthcare state and legislature for Covid-19 varied greatly worldwide.

Aims:

After three years, the social life of most countries worldwide is gradually back to normal. Diagnosis and therapeutics worldwide are formalized now. Improvement of the knowledge about this devastating disease will shed new light on its management and spawn the development of new counter measures. Due to the differences in socioeconomic conditions and policies worldwide, the diagnostic and therapeutic transition should be established.

Methods:

The schedules and techniques of vaccines, drugs, or other therapeutic strategies could be formalized in the future. The origin and hidden nature of Covid-19 biology (relationship between viral strain and drug targeting) should be further investigated. Knowledge and opinion breakthroughs may significantly heighten the quality of preventive and therapeutic strategies against Covid-19.

Results:

To further stabilize the global situation, the issues of viral spread and induced mortality should be emphasized. Existing animal models, pathophysiological knowledge, and therapeutics for different infected patients played vital roles. The diagnostic widening, variants of COVID, and therapeutic selection worldwide totally solve the complex outcomes and promote the curability for infected patients.

Discussion:

Different diagnostic platforms can reach different therapeutic selections, responses, and benefits in the clinic. It will provide advanced diagnostic dimensions, therapeutic paradigms, and drug selection strategies for the purpose of the greatest benefiting and recoveries of Covid-19 patients.

Conclusion:

To speed up the global fight against Covid-19, biomedical knowledge, prophylactic vaccines, and therapeutic paradigms should be updated in dynamic states.

Keywords:

Clinical trial Covid-19 Drug development Infection targets Viral infection Viral pathology Viral prevention

More Related Videos

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

Related Concept Videos

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...

Acute Coronary Syndrome III: Diagnostic Studies

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...

Drug Administration and Therapy Phases: Overview

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

Articles linked to this work by shared authors, journal, and citation graph.

Undesired neural side-effects of a drug, a chemical and genetic interrelated problem.

Central nervous system agents in medicinal chemistry·2010

Treatment of solid tumors and metastases by fibrinogen-targeted anticancer drug therapy.

Medical hypotheses·2006

Individualized cancer chemotherapy integrating drug sensitivity tests, pathological profile analysis and computational coordination - an effective strategy to improve clinical treatment.

Medical hypotheses·2005

Anti-proliferative effects, cell cycle G2/M phase arrest and blocking of chromosome segregation by probimane and MST-16 in human tumor cell lines.

BMC pharmacology·2005

See all related articles